DRUCKEN

Beirat

External Advisory Board

Blaukat, PhD
Andree Blaukat, PhD
Senior Vice President- Head Translational Innovation Platform Oncology, Merck KGaA, Darmstadt

Prof. Dr. Fröhling
Prof. Dr. Stefan Fröhling
Managing Director of the National Cancer Center, Heidelberg, Germany

Platzhalterbild
Cornelis Melief, MD, PhD
Emeritus Professor Internal Medicine, CSO of ISA Pharmaceuticals, Leiden

Mellman, PhD
Ira Mellman, PhD
Vice President Cancer Immunology at Genentech, San Francisco, CA, USA

Prof. Dr. Neubauer
Prof. Dr. Andreas Neubauer
Director Hematology & Oncology, Universitätsklinikum Gießen/Marburg, Germany

Prof. Dr. Sjöblom
Prof. Dr. Tobias Sjöblom
Program Director for U-CAN (Biobank), Uppsala University, Sweden

Interner Beirat